Concepedia

Marc W. Retter

MW

33

Publications

2.3K

Citations

22

H-Index

1993

Active since

Affiliations

Amgen (United States)(Current)

Regeneron (United States)

Corixa Corporation

University of North Carolina at Chapel Hill

Antigen Discovery (United States)

Marc W. Retter is an author at Amgen (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1993–2022

33

Publications

33

A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates

Joyce Chan, Derek E. Piper, Qiong Cao et al. · Proceedings of the National Academy of Sciences · 2009 · 407 citations · Full text

, , +18

Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects

Kannan Gunasekaran, Martin Pentony, Min Shen et al. · Journal of Biological Chemistry · 2010 · 279 citations · Full text

, , +11

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels

Clapton Dias, Adam J. Shaywitz, Scott M. Wasserman et al. · Journal of the American College of Cardiology · 2012 · 233 citations

, , +4

Receptor Editing Occurs Frequently during Normal B Cell Development

Marc W. Retter, David Nemazee · The Journal of Experimental Medicine · 1998 · 200 citations · Full text

A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

Alison Crawford, Lauric Haber, Marcus P. Kelly et al. · Science Translational Medicine · 2019 · 137 citations · Full text

Rows per page

1–5 of 33